insights_auto
Why is NL0 up 4.41%?
Dive Deeperchevron_right
NL0:FRA
Grail Inc
€125.40
arrow_upward
+4.41%(+5.30) 1D
Oct 1, 11:51:19 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NL0...
Open
€123.30
High
€125.40
Low
€123.30
Mkt. cap
6.26B
Avg. vol.
5.00
Volume
108.00
52-wk high
€125.40
52-wk low
€34.00
No. of employees
910
Open
€123.30
High
€125.40
Low
€123.30
Mkt. cap
6.26B
Avg. vol.
5.00
Volume
108.00
52-wk high
€125.40
52-wk low
€34.00
No. of employees
910
News stories
From web sources and news partners
Yahoo Finance
·
17 hours ago
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
Yahoo Finance
·
22 hours ago
Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run.
Investor's Business Daily
·
22 hours ago
This Stock, Up Almost 70%, May Have Found Cancer's Holy 'Grail'
StocksToTrade
·
2 days ago
GRAL Stock Rockets Higher As Traders Hunt Momentum
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021, GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023, EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com